Clin Microbiol Infect:肺炎是细菌性脑膜炎患者入院时的一种常见的并存感染,且与其不利结局相关

2020-12-11 MedSci原创 MedSci原创

肺炎是社区获得性细菌性脑膜炎患者的常见并发感染,但对病程的影响尚不明确。本项前瞻性研究旨在探究脑膜炎患者入院时并存肺炎的表现特征、临床过程和结局,研究结果已在线发表于Clin Microbiol In

肺炎是社区获得性细菌性脑膜炎患者的常见并发感染,但对病程的影响尚不明确。本项前瞻性研究旨在探究脑膜炎患者入院时并存肺炎的表现特征、临床过程和结局,研究结果已在线发表于Clin Microbiol Infect。

研究人员评估了2006年3月至2017年6月入院时伴有肺炎的社区获得性细菌性脑膜炎成年患者。进行逻辑回归分析,以确定入院时肺炎的临床特征预测,并量化肺炎对结果的影响。

 

结果显示,1852例(17%)细菌性脑膜炎中315例(17%)入院时诊断为肺炎,308例(83%)中256例(83%)经胸部X线检查确诊为肺炎。315个病例中256个(81%)为肺炎链球菌感染。多变量分析显示,入院时肺炎与高龄(OR每年增加1.03,95%CI 1.02-1.04,P<0.001)、酗酒(OR 1.96,95%CI 1.23-3.14,P 0.004)、癌症(OR 1. 54,95% CI 1.12-2.13,P 0.008),无耳炎或鼻窦炎(OR 0.44,95% CI 0.32-0.59,P <0.001)和肺炎双球菌(OR 2.14,95% CI 1.55-2.95,P <0.001)。在172例(55%)患者中观察到了格拉斯哥结果量表1-4分的不利结果,87例(28%)患者死亡。在多变量分析中,入院时存在肺炎与不利结局和死亡独立相关(OR 1.48,95% CI 1.12-1.96;P 0.005)。

综上所述,该研究结果表明,细菌性脑膜炎患者入院时肺炎是一种常见的并存感染,并且与患者不利的结局和死亡独立相关。

 

原始出处:

 

A H A Figueiredo, M C Brouwer, et al., Community-acquired pneumonia in patients with bacterial meningitis: a prospective nationwide cohort study. Clin Microbiol Infect. 2020 Apr;26(4):513.e7-513.e11. doi: 10.1016/j.cmi.2019.09.001.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2084618, encodeId=eae320846182f, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Jun 13 06:40:48 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767813, encodeId=dec61e6781385, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Oct 26 21:40:48 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919186, encodeId=52de191918642, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun May 02 00:40:48 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857918, encodeId=8495185e918a9, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Mon May 31 01:40:48 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908499, encodeId=3dad908499a8, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201211/3bb57304272c4b2b86735fa78a30e9bf/99e093a7c19f492aa0811287a9a91807.jpg, createdBy=a0701982805, createdName=慎独, createdTime=Wed Dec 16 11:10:20 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625373, encodeId=00c516253e366, content=<a href='/topic/show?id=9b47e809931' target=_blank style='color:#2F92EE;'>#细菌性脑膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78099, encryptionId=9b47e809931, topicName=细菌性脑膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cb520741736, createdName=jiangfeng5074, createdTime=Sun Dec 13 14:40:48 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907261, encodeId=035d90e2611b, content=患者的多系统治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201212/9d5c6006c70b490395e89db6532a4f69/2cf1fc7201d14d1c93acd965ee56b190.jpg, createdBy=87472521349, createdName=124ddb96m47暂无昵称, createdTime=Sat Dec 12 10:36:39 CST 2020, time=2020-12-12, status=1, ipAttribution=)]
    2021-06-13 xjy02
  2. [GetPortalCommentsPageByObjectIdResponse(id=2084618, encodeId=eae320846182f, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Jun 13 06:40:48 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767813, encodeId=dec61e6781385, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Oct 26 21:40:48 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919186, encodeId=52de191918642, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun May 02 00:40:48 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857918, encodeId=8495185e918a9, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Mon May 31 01:40:48 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908499, encodeId=3dad908499a8, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201211/3bb57304272c4b2b86735fa78a30e9bf/99e093a7c19f492aa0811287a9a91807.jpg, createdBy=a0701982805, createdName=慎独, createdTime=Wed Dec 16 11:10:20 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625373, encodeId=00c516253e366, content=<a href='/topic/show?id=9b47e809931' target=_blank style='color:#2F92EE;'>#细菌性脑膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78099, encryptionId=9b47e809931, topicName=细菌性脑膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cb520741736, createdName=jiangfeng5074, createdTime=Sun Dec 13 14:40:48 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907261, encodeId=035d90e2611b, content=患者的多系统治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201212/9d5c6006c70b490395e89db6532a4f69/2cf1fc7201d14d1c93acd965ee56b190.jpg, createdBy=87472521349, createdName=124ddb96m47暂无昵称, createdTime=Sat Dec 12 10:36:39 CST 2020, time=2020-12-12, status=1, ipAttribution=)]
    2021-10-26 仁者大医
  3. [GetPortalCommentsPageByObjectIdResponse(id=2084618, encodeId=eae320846182f, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Jun 13 06:40:48 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767813, encodeId=dec61e6781385, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Oct 26 21:40:48 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919186, encodeId=52de191918642, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun May 02 00:40:48 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857918, encodeId=8495185e918a9, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Mon May 31 01:40:48 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908499, encodeId=3dad908499a8, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201211/3bb57304272c4b2b86735fa78a30e9bf/99e093a7c19f492aa0811287a9a91807.jpg, createdBy=a0701982805, createdName=慎独, createdTime=Wed Dec 16 11:10:20 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625373, encodeId=00c516253e366, content=<a href='/topic/show?id=9b47e809931' target=_blank style='color:#2F92EE;'>#细菌性脑膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78099, encryptionId=9b47e809931, topicName=细菌性脑膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cb520741736, createdName=jiangfeng5074, createdTime=Sun Dec 13 14:40:48 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907261, encodeId=035d90e2611b, content=患者的多系统治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201212/9d5c6006c70b490395e89db6532a4f69/2cf1fc7201d14d1c93acd965ee56b190.jpg, createdBy=87472521349, createdName=124ddb96m47暂无昵称, createdTime=Sat Dec 12 10:36:39 CST 2020, time=2020-12-12, status=1, ipAttribution=)]
    2021-05-02 sunylz
  4. [GetPortalCommentsPageByObjectIdResponse(id=2084618, encodeId=eae320846182f, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Jun 13 06:40:48 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767813, encodeId=dec61e6781385, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Oct 26 21:40:48 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919186, encodeId=52de191918642, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun May 02 00:40:48 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857918, encodeId=8495185e918a9, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Mon May 31 01:40:48 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908499, encodeId=3dad908499a8, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201211/3bb57304272c4b2b86735fa78a30e9bf/99e093a7c19f492aa0811287a9a91807.jpg, createdBy=a0701982805, createdName=慎独, createdTime=Wed Dec 16 11:10:20 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625373, encodeId=00c516253e366, content=<a href='/topic/show?id=9b47e809931' target=_blank style='color:#2F92EE;'>#细菌性脑膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78099, encryptionId=9b47e809931, topicName=细菌性脑膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cb520741736, createdName=jiangfeng5074, createdTime=Sun Dec 13 14:40:48 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907261, encodeId=035d90e2611b, content=患者的多系统治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201212/9d5c6006c70b490395e89db6532a4f69/2cf1fc7201d14d1c93acd965ee56b190.jpg, createdBy=87472521349, createdName=124ddb96m47暂无昵称, createdTime=Sat Dec 12 10:36:39 CST 2020, time=2020-12-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2084618, encodeId=eae320846182f, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Jun 13 06:40:48 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767813, encodeId=dec61e6781385, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Oct 26 21:40:48 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919186, encodeId=52de191918642, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun May 02 00:40:48 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857918, encodeId=8495185e918a9, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Mon May 31 01:40:48 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908499, encodeId=3dad908499a8, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201211/3bb57304272c4b2b86735fa78a30e9bf/99e093a7c19f492aa0811287a9a91807.jpg, createdBy=a0701982805, createdName=慎独, createdTime=Wed Dec 16 11:10:20 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625373, encodeId=00c516253e366, content=<a href='/topic/show?id=9b47e809931' target=_blank style='color:#2F92EE;'>#细菌性脑膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78099, encryptionId=9b47e809931, topicName=细菌性脑膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cb520741736, createdName=jiangfeng5074, createdTime=Sun Dec 13 14:40:48 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907261, encodeId=035d90e2611b, content=患者的多系统治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201212/9d5c6006c70b490395e89db6532a4f69/2cf1fc7201d14d1c93acd965ee56b190.jpg, createdBy=87472521349, createdName=124ddb96m47暂无昵称, createdTime=Sat Dec 12 10:36:39 CST 2020, time=2020-12-12, status=1, ipAttribution=)]
    2020-12-16 慎独

    学习学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2084618, encodeId=eae320846182f, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Jun 13 06:40:48 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767813, encodeId=dec61e6781385, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Oct 26 21:40:48 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919186, encodeId=52de191918642, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun May 02 00:40:48 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857918, encodeId=8495185e918a9, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Mon May 31 01:40:48 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908499, encodeId=3dad908499a8, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201211/3bb57304272c4b2b86735fa78a30e9bf/99e093a7c19f492aa0811287a9a91807.jpg, createdBy=a0701982805, createdName=慎独, createdTime=Wed Dec 16 11:10:20 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625373, encodeId=00c516253e366, content=<a href='/topic/show?id=9b47e809931' target=_blank style='color:#2F92EE;'>#细菌性脑膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78099, encryptionId=9b47e809931, topicName=细菌性脑膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cb520741736, createdName=jiangfeng5074, createdTime=Sun Dec 13 14:40:48 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907261, encodeId=035d90e2611b, content=患者的多系统治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201212/9d5c6006c70b490395e89db6532a4f69/2cf1fc7201d14d1c93acd965ee56b190.jpg, createdBy=87472521349, createdName=124ddb96m47暂无昵称, createdTime=Sat Dec 12 10:36:39 CST 2020, time=2020-12-12, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2084618, encodeId=eae320846182f, content=<a href='/topic/show?id=61f411e013b' target=_blank style='color:#2F92EE;'>#Micro#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11701, encryptionId=61f411e013b, topicName=Micro)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sun Jun 13 06:40:48 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767813, encodeId=dec61e6781385, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Oct 26 21:40:48 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919186, encodeId=52de191918642, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun May 02 00:40:48 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1857918, encodeId=8495185e918a9, content=<a href='/topic/show?id=3f48525849' target=_blank style='color:#2F92EE;'>#CRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5258, encryptionId=3f48525849, topicName=CRO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c30265, createdName=jiafufeng@yaho, createdTime=Mon May 31 01:40:48 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908499, encodeId=3dad908499a8, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201211/3bb57304272c4b2b86735fa78a30e9bf/99e093a7c19f492aa0811287a9a91807.jpg, createdBy=a0701982805, createdName=慎独, createdTime=Wed Dec 16 11:10:20 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625373, encodeId=00c516253e366, content=<a href='/topic/show?id=9b47e809931' target=_blank style='color:#2F92EE;'>#细菌性脑膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78099, encryptionId=9b47e809931, topicName=细菌性脑膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cb520741736, createdName=jiangfeng5074, createdTime=Sun Dec 13 14:40:48 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907261, encodeId=035d90e2611b, content=患者的多系统治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201212/9d5c6006c70b490395e89db6532a4f69/2cf1fc7201d14d1c93acd965ee56b190.jpg, createdBy=87472521349, createdName=124ddb96m47暂无昵称, createdTime=Sat Dec 12 10:36:39 CST 2020, time=2020-12-12, status=1, ipAttribution=)]
    2020-12-12 124ddb96m47暂无昵称

    患者的多系统治疗

    0

相关资讯

J Transl Med:托珠单抗治疗COVID-19的有效性和安全性分析

托珠单抗可阻断白细胞介素-6(IL-6)的促炎活性,IL-6与肺炎的发生有关,而肺炎是COVID-19患者最常见的死亡原因。一项多中心、单臂、假设驱动的试验探究了托珠单抗治疗COVID-19的有效性和

Science Translational Medicine:救命的氧气为什么会给肺炎患者带来致命伤害?科学家发现意外的关键原因

感染新冠病毒后,从轻症转为重症的一个标志性症状是呼吸急促,患者血液中的氧气水平显着降低,这被称为低氧血症。为了让患者的血氧水平恢复正常,吸氧是治疗时常用的呼吸支持手段。

超过900名美国医护人员死于新冠肺炎 外媒:本可以避免

当地时间11日,《卫报》和非营利机构“凯撒健康新闻”(KaiserHealthNews)向公众披露了其共同发起的项目“牺牲在一线”(LostontheF

Lancet Infect Dis:头孢唑烷-他唑巴坦VS美罗培南治疗院内肺炎的疗效和安全性

抗菌性病原体引起的院内肺炎与高死亡率有关。我们评估了联合抗菌药物头孢唑胺-他唑巴坦vs.美罗培南治疗革兰氏阴性院内肺炎的疗效和安全性,研究结果已在线发表于Lancet Infect Dis。

JAHA:肾素-血管紧张素系统抑制剂与流感和肺炎不良结局的关系

在患有流感或肺炎的患者中,ACE-Is/ARB使用者在控制混杂因素后,入住重症监护病房的风险没有增加,死亡率也略有降低。

TGA:肺炎性肠炎患者死亡率的预测因素

全世界炎症性肠病(IBD)的发病率和患病率正在增加,尤其是在新兴工业化国家。